Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · IEX Real-Time Price · USD
2.790
-0.160 (-5.42%)
May 7, 2024, 4:30 PM EDT - Market closed

LIXT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014 2013 - 2007
Market Capitalization
6581640892122
Upgrade
Market Cap Growth
--37.62%-48.20%-59.29%428.77%-15.54%447.25%47.17%-53.33%31.58%101.93%
Upgrade
Enterprise Value
2131235550122
Upgrade
PE Ratio
-1.04-1.04-1.34-2.43-12.31-3.11-4.22-0.91-0.52-0.84-0.66
Upgrade
PB Ratio
1.571.321.643.428.023.122.181.655.207.666.84
Upgrade
P/FCF Ratio
-1.23-1.23-1.84-3.95-18.85-4.54-5.95-1.16-0.67-1.10-1.11
Upgrade
P/OCF Ratio
-1.23-1.23-1.84-3.95-18.85-4.54-5.95-1.16-0.67-1.10-1.11
Upgrade
EV/EBITDA Ratio
-0.21-0.21-0.49-1.72-10.77-2.05-2.21-0.19-0.43-0.79-0.56
Upgrade
EV/EBIT Ratio
-0.21-0.21-0.49-1.72-10.77-2.05-2.21-0.19-0.43-0.79-0.56
Upgrade
EV/FCF Ratio
-0.25-0.25-0.68-2.78-16.47-2.99-3.13-0.24-0.55-1.04-0.95
Upgrade
Quick Ratio
13.3913.3913.5315.9223.4110.9220.263.500.911.150.94
Upgrade
Current Ratio
13.7313.7314.0516.8124.1511.2320.553.671.982.091.97
Upgrade
Interest Coverage
-312.38-312.38-710.27-906.53-887.65------
Upgrade
Return on Equity (ROE)
-129.70%-129.70%-112.00%-106.00%-132.20%-79.40%-171.60%-148.30%-264.90%-294.90%-636.50%
Upgrade
Return on Assets (ROA)
-119.90%-119.90%-103.00%-101.30%-121.40%-73.30%-137.20%-120.50%-215.10%-236.30%-365.70%
Upgrade
Return on Capital (ROIC)
-127.42%-127.42%-122.19%-140.29%-65.17%-102.30%-51.82%-181.88%-994.09%-911.34%-903.91%
Upgrade
Earnings Yield
-81.06%-96.24%-74.50%-41.13%-8.13%-32.12%-23.71%-110.00%-191.10%-119.23%-152.04%
Upgrade
FCF Yield
-68.41%-81.22%-54.43%-25.33%-5.30%-22.03%-16.79%-85.90%-150.16%-91.12%-89.90%
Upgrade
Buyback Yield / Dilution
-21.10%-21.10%-17.41%-19.48%-0.92%-14.04%-5.34%-16.59%-2.31%-5.38%-6.79%
Upgrade
Total Shareholder Return
-21.10%-21.10%-17.41%-19.48%-0.92%-14.04%-5.34%-16.59%-2.31%-5.38%-6.79%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).